Stay updated on Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial
Sign up to get notified when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.
Latest updates to the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details and location information for the study, replacing the previous version with new content in the Contacts and Locations section.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedSeveral key genetics-related pages, including those on breast cancer and type 2 diabetes, have been removed from MedlinePlus, indicating a significant reduction in available resources on these conditions.SummaryDifference5%
- Check36 days agoChange DetectedNew resources related to genetics and specific conditions like breast cancer and type 2 diabetes have been added, along with links to major health organizations.SummaryDifference0.6%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in CSV, JSON, RIS, and FHIR formats, along with a comprehensive selection of data fields for studies.SummaryDifference5%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.